Skip to main content

Together we are beating cancer

Donate now

Soft tissue sarcoma

Showing 10 out of 10 results
Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023

Fatimah, 19, near her home, and Adam, 23, on holiday. They were both diagnosed with cancer in their mid-teens.

For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer. For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer.

by Tom Bourton | Personal stories | 6 April 2023

6 April 2023

Rebecca and family

This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones. This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones.

by Tom Bourton | Analysis | 15 September 2021

15 September 2021

Dr Sam Behjati

How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers. How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers.

by Joanna Lewin | Interview | 8 September 2021

8 September 2021

Researcher in a lab

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

by Cancer Research UK | News | 28 June 2021

28 June 2021

Lung cancer cells under a microscope

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

by Cancer Research UK | News | 13 November 2020

13 November 2020

Cancer Research UK logo

A Cancer Research UK funded trial will offer new treatments for children and adults with a form of muscle cancer called rhabdomyosarcoma that has returned or does not respond to current treatments. A Cancer Research UK funded trial will offer new treatments for children and adults with a form of muscle cancer called rhabdomyosarcoma that has returned or does not respond to current treatments.

by Cancer Research UK | News | 19 October 2012

19 October 2012

Cancer Research UK logo

Birmingham will be at the forefront of developments in childhood cancer research thanks to the launch of a new team which will co-ordinate groundbreaking clinical trials across the UK. Birmingham will be at the forefront of developments in childhood cancer research thanks to the launch of a new team which will co-ordinate groundbreaking clinical trials across the UK.

by Cancer Research UK | News | 16 April 2010

16 April 2010

Cancer Research UK logo

Childhood cancer survivors who are most at risk of developing a second cancer are more likely to smoke than other childhood cancer survivors - reveals a Cancer Research UK study published in the Journal of the National Cancer Institute* today (Tuesday). Childhood cancer survivors who are most at risk of developing a second cancer are more likely to smoke than other childhood cancer survivors - reveals a Cancer Research UK study published in the Journal of the National Cancer Institute* today (Tuesday).

by Cancer Research UK | News | 29 July 2008

29 July 2008

Cancer Research UK logo

Substances present in the environment may trigger certain rare kinds of childhood cancer, according to a new study1 by Cancer Research UK scientists in Manchester. Substances present in the environment may trigger certain rare kinds of childhood cancer, according to a new study1 by Cancer Research UK scientists in Manchester.

by Cancer Research UK | News | 19 December 2002

19 December 2002